期刊文献+

MHCⅡ类分子转录激活因子锤头状核酶的生物学活性 被引量:1

Biological activity of MHCⅡ transactivator hammerhead ribozyme
暂未订购
导出
摘要 目的探讨MHCⅡ类分子转录激活因子(CⅡTA)锤头状核酶抑制细胞表面MHCⅡ类分子的表达。方法设计并克隆针对CⅡTA第464位点的锤头状核酶(Rz464)及其相应的CⅡTA靶基因,分别插入pGEM-T载体,进行细胞外切割活性鉴定,进一步将Rz464亚克隆入真核表达载体pIRES2-EGFP(pIRES2-EGFP-Rz464,pRz464),并稳定转染Raji细胞株,流式细胞术检测经典的MHCⅡ(HLA-DR-、DP-、DQ)类抗原表达,RT-PCR分析CⅡTA mRNA水平。结果细胞外活性鉴定表明,Rz464具有明显的切割活性。细胞内切割实验显示:pRz464阳性Raji细胞表面HLA-DR、DP、DQ抗原表达分别降低了75.93%、64.14%、78.32%;同时CⅡTA的mRNA含量降低(P<0.05)。结论抗CⅡTA锤头状核酶Rz464可有效抑制MHCⅡ类抗原的表达。 Objective To investigate the inhibiting effects of MHC Ⅱ transactivator ( C Ⅱ TA) hammerhead ribozyme on expression of class Ⅱ major histocompafibility complex ( MHC Ⅱ ) on cell surface. Methods The hammerhead ribozyme recognizing C Ⅱ TA at 464 sites (Rz464) and the CⅡTA target RNA were constructed, and then cloned into the pGEM-T vector,respectively. The recombinant ribozyme and its target RNA were incubated in cell-free conditions. The Rz464 was cloned into the pIRES2-EGFP vector for intracellular analyses ( pIRKS2-EGFP-Rz464, pRz464), and then transfected into Raji cell. The expressions of classical MHC Ⅱ (HLA-DR,-DP,-DQ) were detected by flow cytometry. The mRNA of C Ⅱ TA was analyzed by RT-PCR. Results Rz464 could cleave target RNA exclusively and the expressions of HLADR, -DP, -DQ on pRz464 positive Raji cells were almost totally inhibited. The contents of CⅡ TA mRNA was decreased significantly ( P 〈 0.05). Conclusion Rz464 can inhibit the expression of MHCⅡ molecules.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第3期294-297,共4页 Immunological Journal
基金 广东省自然科学基金(04003959) 广东省人民医院科学技术研究基金(Y2004087)资助项目
关键词 MHCⅡ类分子转录激活因子 核酶 自身免疫性疾病 基因疗法 MHC class Ⅱ transactivator Ribozyme Autoimmune diseases Gene therapy
  • 相关文献

参考文献14

  • 1Tsark EC, Wang W,Teng YC,et al.Differential MHC class Ⅱ-mediated presentation of rbeumatoid arthritis autoantigens by human dendritic cells and macrophages[J].J Immunol,2002,169(11):6625-6633.
  • 2Czaja AJ.Understanding the pathogenesis of autoimmune hepatitis[J].Am J Gastroenterol,2001,96(4):1224-1231.
  • 3Stuve O, Youssef S, Slavin AJ,et al.The role of the MHC class Ⅱ transactivator in class Ⅱ expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease[J].J Immunol,2002,169(12):6720-6732.
  • 4Holling TM,van der Stoep N,Quinten E,et al.Activated Human T Cells Accomplish MHC Class Ⅱ Expression Through T Cell-Specific Occupation of Class Ⅱ Transactivator Promoter Ⅲ[J].J Immunol,2002,168(2):763-770.
  • 5Waldburger JM,Suter T,Fontana A,et al.Selective abrogation of major bistocompatibility complex class Ⅱ expression on extrahematopoietic cells in mice lacking promoter Ⅳ of the class Ⅱ transactivator gene[J].J Exp Med,2001,194(4):393-406.
  • 6Nagarajan UM.Bushey A,Boss JM.Modulation of gene expression by the MHC class Ⅱ transactivator[J].J Immunol,2002,169(9):5078-5088.
  • 7Yard BA, Yedgar S,Scheele M,et al.Modulation of IFN-gamma-induced immunogencity by phosphatidylethanolaminelinked byaluronic acid[J].Transplantation,2002,73(6):984-992.
  • 8Youssef S,Stuve O,Patarroyo JC,et al.The HMG-CoA reductase inhibitor,atorvastatin,promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease[J].Nature,2002,420 (6911):78-84.
  • 9Charreau B,Coupel S,Boulday G,et al.Cyclosporine inhibits class Ⅱ major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class Ⅱ transcriptional activator gene[J].Transplantation,2000,70 (2):354-361.
  • 10Sadeghi MM,Tiglio A,Sadigh K,et al.Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class Ⅱ gene activation by HMGCoA reductase inhibitors[J].Transplantation,2001,71 (9):1 262-1 268.

同被引文献16

  • 1Balducci Silano PL, Suzuki K, Ohta M, et ol. Regulation of major histocompatibility (MHC) class Ⅱ human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class Ⅰ gene expression [ J ]. Endocrinology, 1998, 139 (5): 2 300-2 313.
  • 2Lance EM, Kimura LH, Manibog CN. The expression of major histocompatibility antigens on human articular chondrocytes [J]. Clin Orthop Relat Res, 1993, 291: 266- 282.
  • 3Roura Mir C, Catalfamo M, Sosperdra M, et al. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease[J]. Eur J Immunol, 1997, 27 (12): 3290-3320.
  • 4Harton JA, Ting JP. Class Ⅱ transactivator: mastering the art of major histocompatibility complex expression [ J ]. Mol Cell Biol, 2000, 20 (17): 6 185-6 189.
  • 5Chang CH, Guerder S, Hong SC, et al. Mice lacking the MHC class Ⅱ transactivator (CIITA) show tissue-specific impairment of MHC class Ⅱ expression[J]. Immunity, 1996, 4(2) : 167 - 172.
  • 6Williams GS, Malin M, Vremec D, et al. Mice lacking the transcription factor CIITA-a second look[J]. Int Immunol, 1998, 10 (12): 1 957 - 1 963.
  • 7Itoh Lindstrom Y, Piskttrich JF, Felix N J, et al. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class Ⅱ expression in mice lacking class Ⅱ transactivator due to targeted deletion of the GTP-binding domain[J]. J Immunol, 1999, 163(5): 2425-2431.
  • 8Mora C, Wong FS, Chang CH, et al. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class H-restricted CD4 T cells: studies using NOD/CIITA-deficient mice[J]. J Immunol, 1999, 162 (8): 4 576-4 588.
  • 9Vickers TA, Koo S, Bennett CF, et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis [ J ]. J Biol Chem, 2003, 278 (9): 7 108-7 118.
  • 10Wang Y, Lou S. Direct protective effect of interleukin-10 on articular chondrocytes in vitro [ J ]. Chin Med J (Engl), 2001, 114 (7): 723- 725.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部